Memphis Pharmaceuticals (Egypt) Price on December 25, 2024
| MPCI Stock | 51.98 0.27 0.52% |
If you're considering investing in Memphis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Memphis Pharmaceuticals stands at 51.98, as last reported on the 26th of December, with the highest price reaching 52.98 and the lowest price hitting 51.71 during the day. Memphis Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Memphis Pharmaceuticals has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. By analyzing Memphis Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please exercise Memphis Pharmaceuticals' Downside Deviation of 3.09, risk adjusted performance of 0.0933, and Mean Deviation of 3.23 to check out if our risk estimates are consistent with your expectations.
Memphis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Memphis |
Sharpe Ratio = 0.1235
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MPCI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.18 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.89 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Memphis Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Memphis Pharmaceuticals by adding it to a well-diversified portfolio.
Memphis Pharmaceuticals Valuation on December 25, 2024
It is possible to determine the worth of Memphis Pharmaceuticals on a given historical date. On December 25, 2024 Memphis was worth 52.25 at the beginning of the trading date compared to the closed value of 51.98. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Memphis Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Memphis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Memphis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Memphis Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 52.25 | 52.98 | 51.71 | 51.98 | 13,701 | |
12/26/2024 | 52.25 | 52.98 | 51.71 | 51.98 | 0.00 |
| Backtest Memphis Pharmaceuticals | | | Memphis Pharmaceuticals History | Previous |
Memphis Pharmaceuticals Trading Date Momentum on December 25, 2024
| On December 26 2024 Memphis Pharmaceuticals was traded for 51.98 at the closing time. The highest price during the trading period was 52.98 and the lowest recorded bid was listed for 51.71 . There was no trading activity during the period 0.0. Lack of trading volume on December 26, 2024 did not cause price change. The trading delta at closing time to the current price is 0.52% . |
Price Boundaries
Memphis Pharmaceuticals Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Memphis Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Egyptian Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Memphis Pharmaceuticals December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Memphis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Memphis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Memphis Pharmaceuticals stock market strength indicators, traders can identify Memphis Pharmaceuticals entry and exit signals to maximize returns
Memphis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Memphis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Memphis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Memphis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0933 | |||
| Jensen Alpha | 0.6579 | |||
| Total Risk Alpha | 0.3891 | |||
| Sortino Ratio | 0.205 | |||
| Treynor Ratio | 2.45 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Memphis Stock analysis
When running Memphis Pharmaceuticals' price analysis, check to measure Memphis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Memphis Pharmaceuticals is operating at the current time. Most of Memphis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Memphis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Memphis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Memphis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |